Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID‐19 vaccine.

The study examined the rate of recurrent venous thromboembolism (VTE) after discontinuing anticoagulation in patients who developed VTE within 30 days of receiving a COVID-19 vaccine. The findings indicated a low recurrence rate of VTE after stopping anticoagulant therapy, suggesting a relatively low risk of recurrent thrombotic events post-cessation. The study highlighted the importance of individualized patient assessment when determining the duration of anticoagulant therapy in VTE after COVID-19 vaccination, offering valuable insights for clinicians in managing potential vaccine-related adverse events. [Extracted from the article]